You are here: Industry Insights > immunotherapy

News List

Using Bristol-Myers’ popular leukemia drug to improve anti-PD-1 cancer immunotherapy fiercebiotech
February 22, 2019
Anti-PD-1/L1 therapies, which remove "checkpoints" that prevent the immune system from fighting cancer, have been hailed as a major treatment advance.
Merck's Keytruda hits the skids in pivotal trial, putting its liver cancer nod at risk fiercepharma
February 21, 2019
Merck & Co.’s immunotherapy Keytruda has been hitting its trial targets so often, it’s tempting to think it can't miss. But it can—and Tuesday’s data in liver cancer proves it.
Decipher Biosciences Announces Research Collaboration with Dendreon to Identify Genomic Drivers of Patient Response to Sipuleucel-T pharmafocusasia
February 18, 2019
Decipher Biosciences, a leader in the field of urologic cancer genomics, today announced a research collaboration with Dendreon Pharmaceuticals....
United Neuroscience inches closer to Alzheimer’s vaccine prize pharmaphorum
January 22, 2019
A vaccine for Alzheimer’s disease developed by United Neuroscience has cleared a phase IIa trial, and seems to be free of the toxicity that has scuppered earlier candidates.
GE Healthcare partners with Vanderbilt on AI-based immunotherapy guidance and diagnostics fiercebiotech
January 15, 2019
GE Healthcare is teaming up with Vanderbilt University Medical Center to develop more precise cancer immunotherapy diagnostics that use artificial intelligence to predict both efficacy and potential side effects....
HPV vaccines continue to dominate cancer vaccines landscape pharmaceutical-technology
January 08, 2019
Cancer vaccines are a type of immunotherapy used to either treat existing cancer or prevent the development of cancer.
MabSpace Biosciences merges with bioprocessing technology firm HJB pharmaceutical-technology
January 03, 2019
Hong Kong, S.A.R., China-based biotech company MabSpace Biosciences has signed a definitive agreement to merge with bioprocessing technologies provider HJB to form a biotherapeutics firm, which will be called Transcenta.....
Nature publication reports first-in-human trial of a novel actively personalized therapeutic vaccine for brain cancer firstwordpharma
December 25, 2018
The prospect of an actively personalized approach to the treatment of glioblastoma has moved a step closer with the recent publication in Nature of favorable data from the phase 1 study GAPVAC-101, testing a novel therapeutic concept tailored to specific
Lilly, Aduro Biotech in Immunotherapy Alliance contractpharma
December 20, 2018
Eli Lilly and Co. and Aduro Biotech, Inc. have entered a research collaboration and exclusive license agreement for Aduro's cGAS-STING Pathway Inhibitor program for the development of novel immunotherapies.
BMS looks to RNA splicing to boost immunotherapies pharmaphorum
December 19, 2018
Bristol-Myers Squibb’s quest to claim dominance in the immunotherapy space continues through a new collaboration with Eisai and its US-based precision medicine subsidiary H3 Biomedicine to.....

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page